Approval · Notice of Compliance 148 · 2004
NARDIL: Notice of Compliance 148
Issued January 23, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 148
- Date
- January 23, 2004
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug product manufacturing site, reformulation of drug product
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NARDIL | Not yet assigned | — |
Medicinal ingredients
- PHENELZINE SULFATE 15 MG per TAB